Uridine, 5'-(2-methylpropanoate) (9CI) manufacturers
|
| | Uridine, 5'-(2-methylpropanoate) (9CI) Basic information |
| Product Name: | Uridine, 5'-(2-methylpropanoate) (9CI) | | Synonyms: | Uridine, 5'-(2-methylpropanoate) (9CI);Molnupiravir Impurity 7;((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate;((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate (Molnupiravir Impurity);Monabiravir impurity 7;Zeaxanthin Impurity 12;5'-isobutyryluridine | | CAS: | 886538-48-3 | | MF: | C13H18N2O7 | | MW: | 314.29 | | EINECS: | | | Product Categories: | Modified（deoxy）nucleoside | | Mol File: | 886538-48-3.mol |  |
| | Uridine, 5'-(2-methylpropanoate) (9CI) Chemical Properties |
| density | 1.440±0.06 g/cm3(Predicted) | | pka | 9.39±0.10(Predicted) |
| | Uridine, 5'-(2-methylpropanoate) (9CI) Usage And Synthesis |
| Uses | Uridine 5''-(2-Methylpropanoate) can be used in the preparation of molnupiravir ((EIDD-2801) (CAT# E985795), which is an antiviral agent that is under development for the treatment of COVID-19 and has promising activity against the SARS-CoV-2 virus. |
| | Uridine, 5'-(2-methylpropanoate) (9CI) Preparation Products And Raw materials |
|